|
Market Closed -
Nasdaq
16:00:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 300.88 USD | +0.21% |
|
-9.45% | +22.04% |
| 11-03 | Krystal Biotech Offers Good Prospects Amid Pipeline Delays, RBC Says | MT |
| 11-03 | RBC Lowers Price Target on Krystal Biotech to $375 From $400, Keeps Outperform Rating | MT |
| Market Cap | 8.92B 8B 7.31B 6.67B 12.57B 838B 12.97B 88.09B 35.13B 447B 33.47B 32.75B 1,412B | P/E 2026 * |
39x | P/E 2027 * | 32.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.35B 7.49B 6.85B 6.25B 11.78B 785B 12.15B 82.53B 32.91B 419B 31.35B 30.68B 1,323B | EV / Sales 2026 * |
16.8x | EV / Sales 2027 * | 12.5x |
| Free-Float |
89.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KRYS | Delayed | |
CBOE
| KRYS | Real-time | |
|
Tradegate
| 4KB | Real-time | |
|
Börse Stuttgart
| 4KB | Delayed | |
|
Boerse Muenchen
| 4KB | Real-time | |
|
Deutsche Boerse AG
| 4KB | Delayed | |
|
Borsa Italiana
| 1KRYS | End-of-day quote | |
|
Xetra
| 4KB | Delayed |
Last Transcript: Krystal Biotech, Inc.
| 1 day | +0.21% | ||
| 1 week | -9.45% | ||
| Current month | -9.45% | ||
| 1 month | -7.30% | ||
| 3 months | -7.83% | ||
| 6 months | +1.41% | ||
| Current year | +22.04% |
| 1 week | 281.4 |  | 317 |
| 1 month | 281.4 | | 338.91 |
| Current year | 235.6 | | 382.54 |
| 1 year | 197.13 | | 382.54 |
| 3 years | 93.95 | | 382.54 |
| 5 years | 38.86 | | 382.54 |
| 10 years | 8.03 | | 382.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Suma M. Krishnan
COO | Chief Operating Officer | 61 | 2016-04-14 |
| Chief Executive Officer | 61 | 2016-04-14 | |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 2016-04-14 | |
Suma M. Krishnan
BRD | Director/Board Member | 61 | 2016-04-14 |
Daniel Janney
BRD | Director/Board Member | 60 | 2016-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/14/26 | Free | Director | 1,658 | 0.0056% | ||
| 9/14/26 | Free | Director | 1,658 | 0.0056% | ||
| 9/14/26 | Free | Director | 1,658 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -9.45% | +52.01% | +175.91% | 8.92B | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.05% | 665B | |
| +1.07% | -1.21% | +32.92% | +104.92% | 515B | |
| -0.36% | -3.25% | +45.42% | +65.10% | 381B | |
| -0.14% | -1.87% | +70.06% | +41.09% | 362B | |
| -0.78% | -0.52% | +30.47% | +58.09% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.17% | 289B | |
| +0.03% | -1.20% | +43.79% | +69.83% | 249B | |
| -0.41% | -2.22% | +40.43% | +107.03% | 207B | |
| Average | -0.05% | -2.33% | +41.76% | +86.69% | 418.87B | |
| Weighted average by Cap. | -0.04% | -1.97% | +42.73% | +88.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 497M 446M 408M 372M 701M 46.76B 723M 4.91B 1.96B 24.95B 1.87B 1.83B 78.77B | 635M 569M 520M 475M 895M 59.68B 923M 6.27B 2.5B 31.84B 2.38B 2.33B 101B |
| Net income | 238M 214M 195M 178M 336M 22.38B 346M 2.35B 938M 11.94B 893M 874M 37.69B | 304M 273M 249M 228M 429M 28.61B 443M 3.01B 1.2B 15.27B 1.14B 1.12B 48.2B |
| Net Debt | -563M -505M -462M -421M -794M -52.95B -819M -5.57B -2.22B -28.25B -2.11B -2.07B -89.19B | -986M -884M -808M -738M -1.39B -92.68B -1.43B -9.74B -3.88B -49.45B -3.7B -3.62B -156B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$300.88 | +0.21% | 234,214 |
| 26-11-05 | US$300.25 | -3.41% | 400,940 |
| 26-11-04 | US$310.84 | +1.90% | 414,444 |
| 26-11-03 | US$305.03 | +3.09% | 603,124 |
| 26-11-02 | US$295.90 | -10.95% | 1,203,634 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KRYS Stock
Select your edition
All financial news and data tailored to specific country editions
